190 related articles for article (PubMed ID: 34849372)
1. Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC.
De Battista D; Zamboni F; Gerstein H; Sato S; Markowitz TE; Lack J; Engle RE; Farci P
J Hepatocell Carcinoma; 2021; 8():1399-1413. PubMed ID: 34849372
[TBL] [Abstract][Full Text] [Related]
2. Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology.
Paslaru L; Bindea G; Nastase A; Sorop A; Zimbru C; Herlea V; Hrehoret D; Brasoveanu V; Zamfir R; Dima S; Popescu I
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557005
[TBL] [Abstract][Full Text] [Related]
3. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
4. Identification of Two Distinct Immune Subtypes in Hepatitis B Virus (HBV)-Associated Hepatocellular Carcinoma (HCC).
De Battista D; Yakymi R; Scheibe E; Sato S; Gerstein H; Markowitz TE; Lack J; Mereu R; Manieli C; Zamboni F; Farci P
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611048
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
[TBL] [Abstract][Full Text] [Related]
7. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
9. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Jin YJ; Byun S; Han S; Chamberlin J; Kim D; Kim MJ; Lee Y
BMC Med Genomics; 2019 Dec; 12(Suppl 8):175. PubMed ID: 31856847
[TBL] [Abstract][Full Text] [Related]
10. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
11. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
[TBL] [Abstract][Full Text] [Related]
12. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.
D'souza S; Lau KC; Coffin CS; Patel TR
World J Gastroenterol; 2020 Oct; 26(38):5759-5783. PubMed ID: 33132633
[TBL] [Abstract][Full Text] [Related]
15. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population.
Rahat B; Kiran M; Saxena R; Chawla YK; Sharma RR; Kaur J
J Clin Exp Hepatol; 2012 Jun; 2(2):104-11. PubMed ID: 25755418
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
Sun S; Li Y; Han S; Jia H; Li X; Li X
BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
[TBL] [Abstract][Full Text] [Related]
17. Distinction immune genes of hepatitis-induced heptatocellular carcinoma.
Hu J; Gao DZ
Bioinformatics; 2012 Dec; 28(24):3191-4. PubMed ID: 23104883
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
19. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.
Alavian SM; Haghbin H
Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803
[TBL] [Abstract][Full Text] [Related]
20. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
